Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;79(2):283-286.
doi: 10.1007/s12020-022-03258-7. Epub 2022 Dec 27.

Looking at the spine in controlled Acromegaly

Affiliations
Comment

Looking at the spine in controlled Acromegaly

Maria Francesca Birtolo et al. Endocrine. 2023 Feb.

Abstract

Skeletal fragility with high risk of vertebral fractures (VFs) is an emerging complication of growth hormone (GH) hypersecretion. VFs often coexist with spine arthropathy and both clinical conditions negatively impact on quality of life of acromegalic subjects. Management of spine osteopathy and arthropathy in acromegaly could be challenging since both complications can persist or even progress after biochemical control of disease. This article analyzes the latest evidence about possible pathophysiological links between VFs and spine arthropathy in active and controlled acromegaly, as well as the diagnostic and therapeutic aspects concerning the holistic management of acromegalic osteo-arthropathy.

Keywords: Acromegaly; Arthropathy; Osteopathy; Quality of life; Vertebral fractures.

PubMed Disclaimer

Comment on

  • Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life.
    Cangiano B, Giusti E, Premoli C, Soranna D, Vitale G, Grottoli S, Cambria V, Mantovani G, Mungari R, Maffei P, Dassie F, Giampietro A, Chiloiro S, Tanda ML, Ippolito S, Cannavò S, Ragonese M, Zambon A, Persani L, Fatti LM, Scacchi M; “PRO-ACRO” study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE). Cangiano B, et al. Endocrine. 2022 Sep;77(3):510-518. doi: 10.1007/s12020-022-03106-8. Epub 2022 Jul 2. Endocrine. 2022. PMID: 35779206 Free PMC article.

References

    1. M. Fleseriu, A. Barkan, M. Del Pilar Schneider, Y. Darhi, A. de Pierrefeu, A. Ribeiro-Oliveira Jr., S. Petersenn, S. Neggers, S. Melmed, Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2), 296–307 (2022). https://doi.org/10.1007/s11102-021-01198-5 - DOI
    1. M.D. Whittington, K.A. Munoz, J.D. Whalen, A. Ribeiro-Oliveira, J.D. Campbell, Economic and clinical burden of comorbidities among patients with acromegaly. Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc. 59, 101389 (2021). https://doi.org/10.1016/j.ghir.2021.101389 - DOI
    1. I.C.M. Pelsma, N.R. Biermasz, W.R. van Furth, A.M. Pereira, H.M. Kroon, M. Kloppenburg, K. Claessen, Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up. J. Clin. Endocrinol. Metab. 106(1), 188–200 (2021). https://doi.org/10.1210/clinem/dgaa747 - DOI
    1. I.C.M. Pelsma, H.M. Kroon, V.R. van Trigt, A.M. Pereira, M. Kloppenburg, N.R. Biermasz, K. Claessen, Clinical and radiographic assessment of peripheral joints in controlled acromegaly. Pituitary 25(4), 622–635 (2022). https://doi.org/10.1007/s11102-022-01233-z - DOI
    1. B. Cangiano, E. Giusti, C. Premoli, D. Soranna, G. Vitale, S. Grottoli, V. Cambria, G. Mantovani, R. Mungari, P. Maffei, F. Dassie, A. Giampietro, S. Chiloiro, M.L. Tanda, S. Ippolito, S. Cannavò, M. Ragonese, A. Zambon, L. Persani, L.M. Fatti, M. Scacchi, Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine 77(3), 510–518 (2022). https://doi.org/10.1007/s12020-022-03106-8 - DOI

MeSH terms

Substances

LinkOut - more resources